|
|
|
Quanterix Corporation (NASDAQ: QTRX) |
|
|
|
| |
Quanterix Corporation Outlook |
On November 13 2024 the Quanterix Corporation provided following guidance
nnQuanterix Corporation Issues Preliminary Financial Results for Q3 2024nn
BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a pioneering company dedicated to advancing scientific exploration via ultra-sensitive biomarker detection technologies, has released its preliminary financial results for the third quarter ending September 30, 2024. In addition, the company has reaffirmed its financial guidance for the full year of 2024. However, the specific revenue and profit figures pertaining to this guidance were not disclosed in the announcement.
Despite this omission, Quanterix remains focused on sustaining its robust momentum in the market. The company also revealed plans to restate certain financial statements from prior periods to rectify non-cash errors identified in those reports.
Quanterix continues to make significant strides in the field, ensuring that its innovative approaches contribute meaningfully to scientific research and discovery.,
|
On February 26 2024 the Quanterix Corporation provided following guidance
Additionally, Quanterix reaffirmed its guidance for the full year 2023, highlighting its commitment to transparency and accuracy in financial reporting. The rescheduled earnings conference call will provide shareholders with a comprehensive overview of the company's performance in the fourth quarter, allowing s and investors to gain insights into Quanterix's strategic initiatives and financial outlook.
The decision to reschedule the earnings release and conference call underscores Quanterix's dedication to ensuring the accuracy and completeness of its financial disclosures. By aligning the release of its financial results with the filing of its Annual Report on Form 10-K, Quanterix aims to provide stakeholders with a more cohesive and comprehensive view of its financial performance for the year ended December 31, 2023.
Quanterix's decision to reaffirm its 2023 guidance further demonstrates the company's confidence in its strategic direction and financial outlook. By maintaining transparency and consistency in its communications with shareholders, Quanterix aims to foster trust and confidence among investors, s, and other stakeholders. The rescheduled earnings conference call on February 29, 2024, will serve as an opportunity for Quanterix to provide a detailed update on its financial results and strategic priorities, and to address any questions or concerns from stakeholders.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
